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Does physician education of alternative therapies for obstructive sleep apnea
improve utilization?
Colin Huntley MD
Jefferson Sleep Disorders Center – Thomas Jefferson University

Background
The rate of CPAP compliance has ranged from 2983% in the literature. Alternative strategies including
oral appliances, body positioning devices, and surgery
need to be considered for those patients intolerant to
CPAP.
In August 2014, we performed our first upper
airway stimulator (UAS) insertion. This is a new
technology for use in patients with OSA unable to
tolerate CPAP that induces muscle tone at the base of
tongue and palate during sleep, thus relieving
obstruction.
We hypothesize that after institution of a UAS
program, sleep physician education, and readily
available literature, the utilization of alternative
therapies for patients unable to tolerate CPAP would
improve.

Methods
We conducted a retrospective chart review of
patients in the Jefferson Sleep Disorder Center (JSDC)
consisting of 2 cohorts of patients. The first was a group
of patients undergoing PSG in March, 2014 prior to
institution of the UAS program. The second was a cohort
of patients undergoing PSG in July 2016 after institution
of the UAS program, positive initial results, readily
available literature in the JSDC, and a physician inservice including details of the procedure and outcome,
quality of life, and complication rate data.
We collected demographic and PSG data. We
then reviewed the electronic medical record and
assessed the first and second followup at the JSDC for
CPAP compliance data and referral for oral appliance,
body positioning device, or surgical evaluation.

March 2014

July 2017

Number of patients undergoing 196
Sleep Study
Dx w OSA and Rx CPAP
118

184

Followed up/Inc criteria

69

110

77

2014

2016

p value

Gender

49M 28F

44M 25F

Age

54.70±12.29

55.20±13.10

0.623

AHI

26.13±22.48

31.20±26.16

0.470

Nadir

78.12%±10.42

79.24%±9.45

0.226

ESS

11±6.99

11.14±6.05

0.636

2014

2016

p value

Time to FU

143.99±206.73 103.79±99.09

<0.0001

% Days used

67.58%±32.37

0.182

77.20%±29.40

Usage per night 226.31±178.24 281.38±164.56 0.541
(minutes)
Pressure
8.80±3.27
8.50±2.54
0.191
AHI

3.39±4.05

5.36±4.03

0.368

Compliance

36%

48%

0.026

2014

2016

p value

All referral

13

17

0.306

Positioning Device

1

1

1

OAT

5

3

0.722

Surgery

7

13

0.071

Results
196 patients underwent a sleep study in March
2014 with 77 meeting inclusion criteria. 184
patients underwent a sleep study in July 2016
with 69 meeting inclusion criteria. There was no
difference in gender, age, AHI, O2 Nadir, Epworth
sleepiness score (ESS), percent days using CPAP
at initial followup, compliance at initial followup,
treatment AHI at initial followup, compliance at
second followup, treatment AHI at second
followup, or surgical referrals after
noncompliance at second followup between the
two groups.
There was a significant difference in time to
initial followup (p<0.001). The proportion of
patients sent for a surgical referral after initial
followup was greater in those undergoing PSG in
2016 and this approached significance (p=0.071).

Conclusion
CPAP remains the first line therapy for OSA.
However, there are numerous alternative treatment
options for those unable to tolerate CPAP and
institution of a UAS program along with physician
education can increase utilization of these therapies.

